Company Overview of Juno Therapeutics Inc.
Mark W. Frohlich M.D.
Executive Vice President of Portfolio Strategy, Juno Therapeutics Inc.
|Age||Total Calculated Compensation||This person is connected to 0 Board Members in 0 different organizations across 2 different industries.|
As of Fiscal Year 2015
307 Westlake Avenue NorthPhone: 206-582-1600
Seattle, Washington 98109
Board Members MembershipsThere is no Board Members Memberships data available.
Harvard Medical School
University of California-San Francisco
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
|Randal J. Kirk J.D.||Chairman, Chief Executive Officer and President|
|$4.4M||Compensation as of Fiscal Year 2015.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.